@@Mango22 I've explained this half a dozen times before so you should be able to see in past posts easily enough with a few search parameters on my posting history in OCC. Mostly to do with a linear accrual recognition of BioHOrizons contract payments across the period - though R&D rebates, etc, in the mix too.
Ann: Quarterly Activity Report & Appendix 4C, page-18
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.5¢ |
Change
0.035(7.29%) |
Mkt cap ! $107.9M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 53.0¢ | 50.0¢ | $1.329M | 2.593M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28629 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.5¢ | 11758 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |